Cite

HARVARD Citation

    Hohenberger, P. et al. (n.d.). 3035 Vascular Disrupting Agent ASA 404 evaluated in human isolated ventilated and perfused lung lobes containing NSCLC. European journal of cancer. pp. S608-. [Online]. 
  
Back to record